Europe considers accelerated GMO import approval process to facilitate mini US trade deal

Brussels is ready to offer to speed up the approval process for genetically modified organisms imported into the EU, as part of a mini trade agreement with Washington.

European Commission President Ursula von der Leyen wants to strike such a deal with U.S. President Donald Trump by March 18.

POLITICO spoke with four diplomats and three EU officials who said that as part of the deal, the EU could commit to accelerating its system of checks and approvals for GMOs ….

The Office of the U.S. Trade Representative stated in a report on EU trade barriers last year that “the lengthy EU approval process” for GMO crops of “on average 7.5 years” has caused U.S. farmers “an annual loss of approximately $2 billion per year.”

The Commission admits that this process can be accelerated …. According to one official who identified themselves as “a very interested bystander,” EU countries could give EFSA more money to hire more GMO experts.

“There might be a question of giving [EFSA] more resources or ensuring that they give [GMO approvals] more priority, even if that’s at the cost of priorities elsewhere,” the official said. “Perhaps they need more people in their gene assessment unit?”

Read the original post

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-05-01-at-11.56.24-AM
‘Science moves forward when people are willing to think differently’: Memories of DNA maverick Craig Venter
Screenshot-2026-04-03-at-11.15.51-AM
Paraben panic: How a flawed study, media hype, and chemophobia convinced the public of the danger of one of the safest classes of preservatives
79d03212-2508-45d0-b427-8e9743ff6432
Viewpoint: The Casey Means hustle—Wellness woo opportunism dressed up as medical wisdom
Screenshot-PM-24
Viewpoint: The herbicide glyphosate isn’t perfect. Banning it would be far worse.
ChatGPT-Image-Mar-27-2026-11_27_05-AM
The myths of “process”: What science says about the “dangers’ of synthetic products and ultra-processed foods
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
ChatGPT-Image-Apr-30-2026-12_21_05-PM-2
The tech billionaires behind the immortality movement
ChatGPT-Image-Mar-3-2026-01_17_14-PM
MAHA wellness influencers deride proven anxiety medications, tout lifestyle fixes
ChatGPT Image Apr 30, 2026, 01_11_41 PM
Trump’s America First health aid cuts: Retrenchment has already hit global malaria, HIV, TB, and polio programs
ChatGPT-Image-May-1-2026-03_16_32-PM
Viewpoint: How ‘health care guru’ Joe Rogan circumvented the FDA’s skepticism on psychedelics
images
The never-ending GMO debate: Pros and cons
ChatGPT-Image-Apr-30-2026-05_00_48-PM
Wellness grifter physician turned wellness influencer out as surgeon general nominee
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.